Welcome to our dedicated page for Cooper SEC filings (Ticker: COO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cooper Companies, Inc. filings document a Nasdaq-listed medical device company with common stock trading under the symbol COO. Its regulatory disclosures include Form 8-K reports on quarterly results, board and officer changes, annual meeting voting results, and material definitive agreements, including amendments to term loan arrangements.
Proxy materials describe director elections, board committee matters, executive compensation, shareholder proposals, and governance practices. Together, the filings record operating and financial disclosures for CooperVision and CooperSurgical, capital structure information, debt arrangements, stockholder voting mechanics, and risk and governance topics relevant to the company’s contact lens, fertility, and women’s healthcare businesses.
Albert G. White III, President & CEO and Director of Cooper Companies (COO), reported an insider purchase of 10,000 shares at $68.39 on 09/05/2025, increasing his beneficial ownership to 226,151 shares. The Form 4 was filed individually and signed by an attorney-in-fact on behalf of Mr. White.
Gerard H. Warner III, President of CooperVision and an officer of Cooper Companies (COO), acquired 1,450 shares of Company common stock on 09/05/2025 at $69.23 per share. After the purchase he beneficially owned 18,319 shares. The Form 4 was submitted by a single reporting person and signed by an attorney-in-fact on behalf of Mr. Warner.
Daniel G. McBride, EVP & Chief Operating Officer of The Cooper Companies (COO), reported an open-market purchase of company stock. The Form 4 discloses a purchase of 3,000 shares of Common Stock at a price of $65.04 per share, recorded as a purchase transaction. After this transaction, Mr. McBride directly beneficially owns 63,120 shares and indirectly beneficially owns 94,496 shares through The McBride Family Trust. No derivative securities are reported on this form.
Cooper Companies executive Brian G. Andrews reported an open‑market purchase of 1,525 shares of common stock at a weighted average price of $65.68, acquired indirectly through the Andrews Family Trust where he and his spouse are co‑trustees.
Following this transaction on 09/02/2025, the trust holds 22,191 shares of Cooper Companies, while Andrews directly owns 6,902 shares. His direct holdings include 288 shares previously acquired under the company’s employee stock purchase plan in early 2025.
The Cooper Companies, Inc. reported third-quarter fiscal 2025 results showing continued activity across acquisitions, financing and operations. The company completed acquisitions including obp Surgical for $100.0 million and a fertility company for $33.5 million in 2024, and earlier acquired select Cook Medical assets for $300.0 million (present value $291.6 million). Consolidated gross margin was 65% for the quarter (66% prior-year quarter) driven lower primarily by inventory write-offs related to a product line exit.
Liquidity and capital: working capital was $1,127.7 million versus $928.7 million a year earlier. Total outstanding debt carried an aggregate amount of $2.5 billion; $930.2 million was outstanding on the 2024 Revolving Credit Facility at a weighted-average interest rate of 5.43% and $1,500.0 million remained under the 2021 Term Loan. Share repurchases in the quarter totaled 0.7 million shares for $52.2 million, with $163.6 million remaining authorized. Management disclosed a material weakness in IT general controls impacting CooperSurgical and is implementing remediation steps.
The Cooper Companies, Inc. furnished a current report to disclose that it issued a press release announcing its results for the fiscal third quarter ended July 31, 2025.
The press release, dated August 27, 2025, is provided as Exhibit 99.1 and is incorporated by reference into this report, but is designated as “furnished” rather than “filed” under securities laws. The company also includes an Inline XBRL cover page data file as Exhibit 104.1, and the report is signed by President and Chief Executive Officer Albert G. White III.